Area of research
Immunology · Molecular Biology
Research interest
My interest in micro planes has resulted in a research group in the MAV Group which we started in 2001, by producing one of the lightest airframe (7.3g) membrane-structure micro air vehicles in the world at that time. In the last few years we have been awarded 8 grants by the USAF for work on understanding the dynamic response of fixed, rotary and flapping wing MAVs in turbulent flow, including 5 Window on Science travel grants to give invited talks at US and European meetings. Most research is now focussed on understanding MAVs and the influence of both their design type (e.g. fixed wing vs flapping vs rotary) and how these differing designs cope with the effects of atmospheric turbulence. I supervise several PhD students in this area.
Exosome-primed T cell immunity is facilitated by complement activation.
CD39 polymorphism enables lung thrombosis in sickle cell disease.
8-Aminoguanine protects against paclitaxel-induced neural degeneration and mechanical allodynia
Quantifying local strain field and deformation in active contraction of bladder using a pretrained transformer model: A speckle-free approach
LYVAC/PDZD8 is a lysosomal vacuolator.
Spatiotemporal binding of cyclophilin A and CPSF6 to capsid regulates HIV-1 nuclear entry and integration
Kidney-specific WNK1 amplifies kidney tubule responsiveness to potassium via WNK body condensates
Cited4a limits cardiomyocyte dedifferentiation and proliferation during zebrafish heart regeneration.
Fetoplacental extracellular vesicles deliver conceptus-derived antigens to maternal secondary lymphoid tissues for immune recognition.
Vasa vasorum plexus formation in intracranial aneurysm associates with microcalcification and wall thickening.
Data from Endometriosis-Associated Mesenchymal Stem Cells Support Ovarian Clear Cell Carcinoma through Iron Regulation
Long-range genomic loci stochastically assemble into combinatorial forms of chromosome skeleton
Supplementary Data from Endometriosis-Associated Mesenchymal Stem Cells Support Ovarian Clear Cell Carcinoma through Iron Regulation
Modelling post-implantation human development to yolk sac blood emergence.
Carcinoma-associated mesenchymal stem cells promote ovarian cancer heterogeneity and metastasis through mitochondrial transfer
The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD
The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD.
Lung microvascular occlusion by platelet-rich neutrophil-platelet aggregates promotes cigarette smoke-induced severe flu.
Ribosome-Associated Vesicles promote activity-dependent local translation in neurons
CD91 and Its Ligand gp96 Confer Cross-Priming Capabilities to Multiple APCs during Immune Responses to Nascent, Emerging Tumors.
Monoamine transporter ubiquitination and inward-open conformation synergistically maximize transporter endocytosis.
Figure S3 from CD91 and Its Ligand gp96 Confer Cross-Priming Capabilities to Multiple APCs during Immune Responses to Nascent, Emerging Tumors
Cited4a limits cardiomyocyte dedifferentiation and proliferation during zebrafish heart regeneration
Figure S4 from CD91 and Its Ligand gp96 Confer Cross-Priming Capabilities to Multiple APCs during Immune Responses to Nascent, Emerging Tumors
Figure S11 from CD91 and Its Ligand gp96 Confer Cross-Priming Capabilities to Multiple APCs during Immune Responses to Nascent, Emerging Tumors
Figure S9 from CD91 and Its Ligand gp96 Confer Cross-Priming Capabilities to Multiple APCs during Immune Responses to Nascent, Emerging Tumors
Figure S6 from CD91 and Its Ligand gp96 Confer Cross-Priming Capabilities to Multiple APCs during Immune Responses to Nascent, Emerging Tumors
Table S3 from CD91 and Its Ligand gp96 Confer Cross-Priming Capabilities to Multiple APCs during Immune Responses to Nascent, Emerging Tumors
Table S4 from CD91 and Its Ligand gp96 Confer Cross-Priming Capabilities to Multiple APCs during Immune Responses to Nascent, Emerging Tumors
Figure S8 from CD91 and Its Ligand gp96 Confer Cross-Priming Capabilities to Multiple APCs during Immune Responses to Nascent, Emerging Tumors